John Vierling

John Vierling

Direttore/Membro del Consiglio presso ATHENEXPAR
80 anni
Consumer Services
Health Technology
Commercial Services

Profilo

John Moore Vierling is an Independent Director at Athenex, Inc., Chief Hepatology & Director-Baylor Liver Health at Baylor College of Medicine, Director at National Institute of Diabetes & Digestive & Kidney Diseases, and Member at National Institutes of Health.
He was formerly Chairman at Arbios Systems, Inc., Chairman at Fractyl Health, Inc., Medical Director-Multi Organ Transplantation at Cedars-Sinai Medical Center, Medical Director-Liver Transplantation at the University of Colorado Health Sciences Center, President at American Association for The Study of Liver Diseases, and Secretary & Treasurer at Digestive Disease Week.
He was also Chairman of the American Liver Foundation from 1994 to 2000.
Dr. Vierling received his undergraduate degree from Stanford University and his doctorate from Stanford University School of Medicine.

Posizioni attive di John Vierling

SocietàPosizioneInizio
ATHENEXPAR Direttore/Membro del Consiglio 01/04/2019
Corporate Officer/Principal 01/04/2005
Corporate Officer/Principal -
Direttore/Membro del Consiglio -

Precedenti posizioni note di John Vierling

SocietàPosizioneFine
Segretario Aziendale 01/07/2013
Presidente 01/12/2007
Presidente 01/01/2000
FRACTYL HEALTH, INC. Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di John Vierling

Formazione di John Vierling

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

90

Relazioni di 1° grado

13

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private13

Health Technology

Health Technology

Consumer Services

Health Services

Consumer Services

Government

Consumer Services

Government

Commercial Services

Commercial Services

Commercial Services

Health Technology

Consumer Services

  1. Mercati
  2. Insiders
  3. John Vierling
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA